All Pharma articles – Page 33
-
News
All NHS reconfigurations look set to progress despite moratorium
The government’s new set of tests for service reconfigurations has yet to lead to a scheme being turned down, an investigation by HSJ has found.
-
News
Pharma lead issues warning on pricing
The government’s proposed reform of NHS drug pricing may not save the service money, the head of the Association of the British Pharmaceutical Industry has warned.
-
Comment
Treading softly on cancer's dreams
It is good to see old fashioned centralisation is alive and well in sensitive matters.
-
News
Leading lights to judge HSJ ideas awards
Leading lights from the public service and business worlds have agreed to help judge the inaugural HSJ and Capgemini Liberating Ideas Awards.
-
Comment
'Complaints about NICE on one page and useless, costly drugs on another'
After a summer in which Labour’s health team was off fighting a leadership contest and the Liberal Democrat team was co-opted into government, health politics are livening up. No more Mr Nice Guy seems to be John Healey’s message.
-
News
NHS facing £6bn shortfall - Kings Fund
An ageing population and inflation-busting health costs will leave the NHS around £6 billion a year short, despite government promises to protect its funding, a leading think-tank has said.
-
News
Pledge to cut anti-psychotic drug use
A cut in the use of anti-psychotic drugs for patients with dementia is among a number of pledges put forward by a new coalition of 44 organisations.
-
News
PCTs differ widely over antibiotics prescription
There are wide disparities in antibacterial drugs prescribing by primary care trust area, figures shared exclusively with HSJ reveal.
-
News
Scotland to press ahead with free prescriptions
The Scottish government will press ahead with plans to scrap prescription charges entirely, health secretary Nicola Sturgeon has confirmed.
-
News
Reckitt Benckiser fined for anti-competitive activity
Household goods giant Reckitt Benckiser has been fined £10.2m for abusing its dominant position in the supply of its Gaviscon heartburn treatment to the NHS.
-
Comment
'Lansley needs to make the intellectual case for PCT upheaval'
Who caught my attention at the Tory conference this year? Not Andrew Lansley, I think. He had his £164m cancer screening announcement pinched by David Cameron (a PM’s prerogative) and also made a rather lacklustre speech of his own from the platform.
-
News
NHS must not 'slide back' during transition period, warn pharmacists
The NHS must not wait until GP commissioning arrangements are up and running before starting to try and achieve improved clinical outcomes, the National Pharmacy Association has warned.
-
HSJ Knowledge
Open innovation in healthcare
The concept of open innovation (OI); in which organisations collaborate on research has the potential to contribute to improvements in the quality and safety of healthcare. It is increasingly recognised in the NHS, but how can trusts get involved?
-
News
List of PCT functions drawn up to aid formation of GP consortia
A list of their functions has been sent to primary care trusts to aid discussions over the future transfer of commissioning powers with fledgling GP consortia.
-
News
UK 'behind on pain management'
Many British patients are receiving inadequate chronic pain management, a report has revealed.
-
Information
Research to the rescue!
LIBERAL DEMOCRAT FRINGE - The business secretary was committed to high quality scientific research, Baroness Northover stressed today.
-
News
HIV cases predicted to rise
The NHS is braced for a sharp rise in patients seeking treatment for HIV, figures show.
-
News
Bigger role for pharmacists could save £800m
More than £800m could be saved from NHS budgets by making more use of the skills of pharmacists, according to an influential think tank.
-
News
Call for 'diagnostic cockpit' to reduce drug errors
Doctors should be provided with a “diagnostic cockpit” to reduce the risk of potentially dangerous errors being made during their initial assessment of patients admitted to hospital, a senior consultant has said.